Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort

Recruiting

• Conditions: Acute Myocardial Infarction; Adverse Event

• Registration Number: NCT05862103
• Lead Sponsor: Yu Bo

Brief Summary

AMI Survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-12-21
• Study First Submitted: 2023-05-08
• Study First Submitted QC: 2023-05-08
• Study First Posted: 2023-05-17
• Status Verified: 2025-08
• Primary Completion: 2025-08-30
• Last Update Submitted: 2025-08-31
• Last Update Posted: 2025-09-03
• Study Completion: 2026-12-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 15000

Inclusion Criteria

• AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit.
• Telephone to obtain informed consent from the subjects/family members of the subjects.

Exclusion Criteria

• Not available

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of MACCE	5 years after discharge	the incidence of MACCE (death, heart failure, rehospitalization, re-myocardial infarction, re-myocardial revascularization, stroke, malignant arrhythmia, bleeding events, etc.) in AMI patients

Secondary Outcome Measures

Name	Time	Method
Differences of MACCE between the optimized group and the non-optimized group	5 years after discharge	Differences of the MACCE between the optimized group and the non-optimized group
Differences of the MACCE between OCT-guided group and the coronary angiography -guided group	5 years after discharge	Differences of the MACCE between OCT-guided group and the coronary angiography -guided group
Differences of MACCE between defer PCI group and direct PCI group	3 and 5 years after discharge	Differences of MACCE between defer PCI group and direct PCI group
Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group	5 years after discharge	Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group

Trial Locations

Locations (18)

Beijing An Zhen Hospital, Capital Medical University; 🇨🇳 Beijing, Beijing Municipality, China

Beijing Chao-Yang Hospital, Capital Medical University; 🇨🇳 Beijing, Beijing Municipality, China

Peking University First Hospital; 🇨🇳 Beijing, Beijing Municipality, China

Guangdong general hospital; 🇨🇳 Guangzhou, Guangdong, China

The first affiliated hospital of Guangxi medical university; 🇨🇳 Nanning, Guangxi, China

Second hospital of hebei medical university; 🇨🇳 Shijiazhuang, Hebei, China

Daqing Oil Field Hospital; 🇨🇳 Daqing, Heilongjiang, China

The First Affiliated Hospital of Zhengzhou University; 🇨🇳 Zhengzhou, Henan, China

Zhongda Hospital Southeast University; 🇨🇳 Nanjing, Jiangsu, China

The Second Affiliated Hospital of Nanchang University; 🇨🇳 Nanchang, Jiangxi, China

Scroll for more (8 remaining)